Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis. [PDF]
J Oncol Pharm PractGurumurthy G +3 more
europepmc +1 more source
Real-world experience of thrombopoietin receptor agonists in pediatric immune thrombocytopenia: a report from a Chinese tertiary children's hospital. [PDF]
Transl PediatrFan J +7 more
europepmc +1 more source
Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials. [PDF]
Biomed RepShen N +7 more
europepmc +1 more source
Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia. [PDF]
Int J Gen MedZhao R, Ji D, Zhou Y, Qi L, Li F.
europepmc +1 more source
Thrombopoietin Receptor Agonists: A New Immune Modulatory Strategy in Immune Thrombocytopenia?
Seminars in Hematology, 2016 In 2008, new drugs that mimic the effects of thrombopoietin became available for the treatment of primary immune thrombocytopenia, eg, romiplostim and eltrombopag.
Alexandra Schifferli, Thomas Kühne
exaly +2 more sources
Efficacy and Safety and Analysis of Thrombopoietin Receptor Agonists for the Treatment of Immune Thrombocytopenia in Adults: Analysis of a Systematic Review and Network Meta-Analysis of Randomized Controlled Trials and Results of Real-World Safety Data [PDF]
Frontiers in MedicineNi Zhang, Yumeng Liu
exaly +2 more sources
The Efficacy and Safety of Thrombopoietin Receptor Agonists in Solid Tumors With Chemotherapy-Induced Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [PDF]
Frontiers in PharmacologyLai Y +7 more
exaly +2 more sources